Garde Capital’s Core Laboratories CLB Stock Holding History

Garde Capital’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5	Closed	-$58	–	354
2025 Q2	$58	Hold	5	–	–	﹤0.01%	825
2025 Q1	$75	Buy	+5	New	+$84	﹤0.01%	811
2019 Q3	–	Sell	-4,315	Closed	-$226K	–	142
2019 Q2	$226K	Hold	4,315	–	–	0.04%	129
2019 Q1	$297K	Hold	4,315	–	–	0.05%	111
2018 Q4	$257K	Hold	4,315	–	–	0.05%	141
2018 Q3	$363K	Hold	4,315	–	–	0.06%	136
2018 Q2	$545K	Hold	4,315	–	–	0.09%	107
2018 Q1	$467K	Hold	4,315	–	–	0.08%	108
2017 Q4	$473K	Hold	4,315	–	–	0.09%	111
2017 Q3	$426K	Hold	4,315	–	–	0.08%	112
2017 Q2	$437K	Buy	+4,315	New	+$465K	0.11%	74

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Garde Capital's CLB Position: Q3 2025 in Review

Garde Capital sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 5 shares — an estimated $58 sold.

Garde Capital first reported a position in CLB in Q2 2017 and held it in 11 quarters. The position peaked at $545K in Q2 2018. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

Garde Capital reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
Garde Capital sold 5 Core Laboratories shares in Q3 2025, an estimated $58.
Garde Capital first reported a position in Core Laboratories in Q2 2017 and held it in 11 quarters.
Garde Capital's Core Laboratories position peaked at $545K in Q2 2018.
190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.